{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:30:19Z","timestamp":1761327019763,"version":"build-2065373602"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>This study aimed to establish the correlation between activated partial thromboplastin time (aPTT) in seconds and ratio, first derivative peak (Max1), second derivative peak (Max2), second derivative minimum peak (Min2), and delta-OD of clot waveform analysis in patients diagnosed with cirrhosis, sepsis, and a control group. The study involved a series of cases using the Bayesian ANOVA model with Bayes factor (BF) estimated using the Markov Chain Monte Carlo sampling method with 2 chains. Each chain consisted of 10 000 repetitions and started 5 000 times to predict the variables aPTT (s), aPTT (ratio), Max1, Max2, Min2, and delta-OD respectively across the 3 study groups. The model used was variable\u2009~\u2009stage \u2013 1. This analysis illustrates the adjustment of the posterior proportion for multiple testing by setting the prior probability of the initial hypothesis to 0.5 for all comparisons. There is insufficient evidence that aPTT (s), aPTT (ratio), and Min2 differ between the study groups (0\u2009&lt;\u2009BF\u2009&lt;\u20093). There is compelling evidence for the Max1 value in both the sepsis group and the control group (BF10\u2009=\u200944.042). Additionally, between the sepsis group and the cirrhosis group, there is substantial evidence for the Max1 value (BF10\u2009=\u20095.842). Moreover, there is convincing evidence for the Max2 value in the sepsis group compared to the control group (BF10\u2009=\u200938.782). There is almost confirmatory evidence that the delta-OD value in the sepsis group is higher than that in the control group (BF10\u2009=\u20091251.781). Finally, there is convincing evidence that the sepsis group has a higher delta-OD value than the cirrhosis group (BF10\u2009=\u200935.555). The Max1, Max2, and delta-OD indices effectively reflect coagulation disorders in patients with cirrhosis and sepsis, even when the aPTT test results are within normal limits.<\/jats:p>","DOI":"10.1371\/journal.pone.0334920","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:23:57Z","timestamp":1761326637000},"page":"e0334920","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survey of clot waveform analysis of normal activated partial thromboplastin time in patients with cirrhosis and sepsis at Le Van Thinh hospital"],"prefix":"10.1371","volume":"20","author":[{"given":"Tran Qui","family":"Phuong Linh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8223-1433","authenticated-orcid":true,"given":"Nguyen Thi","family":"Nhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Minh","family":"Thuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Trung","family":"Phuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"8","key":"pone.0334920.ref001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"key":"pone.0334920.ref002","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"M Levi","year":"2010","journal-title":"Crit Care Med"},{"issue":"9","key":"pone.0334920.ref003","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross Talk Pathways Between Coagulation and Inflammation","volume":"118","author":"JH Foley","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"pone.0334920.ref004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-020-03053-y","article-title":"Recent advances in the research and management of sepsis-associated DIC","volume":"113","author":"T Iba","year":"2021","journal-title":"Int J Hematol"},{"issue":"8","key":"pone.0334920.ref005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/cells7080085","article-title":"Coagulation, microenvironment and liver fibrosis","volume":"7","author":"N Bitto","year":"2018","journal-title":"Cells"},{"first-page":"1712","article-title":"Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications.","author":"C Airola","key":"pone.0334920.ref006"},{"issue":"1","key":"pone.0334920.ref007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"T Lisman","year":"2006","journal-title":"Hepatology"},{"first-page":"956","article-title":"No evidence for systemic platelet activation during or after orthotopic liver transplantation.","author":"ITA Pereboom","key":"pone.0334920.ref008"},{"author":"JL Kujovich","key":"pone.0334920.ref009","first-page":"243"},{"issue":"3","key":"pone.0334920.ref010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"A Tripodi","year":"2005","journal-title":"Hepatology"},{"first-page":"1413","article-title":"Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review.","author":"Transfusion Medicine\/Hemostasis Clinical Trials Network.","key":"pone.0334920.ref011"},{"first-page":"3290","article-title":"Viscoelastic tests in liver disease: where do we stand now?.","author":"A Buliarca","key":"pone.0334920.ref012"},{"author":"FH Saner","key":"pone.0334920.ref013","first-page":"179"},{"key":"pone.0334920.ref014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","article-title":"Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia","volume":"38","author":"G Napolitano","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"2","key":"pone.0334920.ref015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Liver European Association for the Study of the","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0334920.ref016","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41598-021-81166-y","article-title":"Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities","volume":"11","author":"CW Tan","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0334920.ref017","doi-asserted-by":"crossref","first-page":"14186","DOI":"10.1038\/s41598-020-71063-1","article-title":"Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections","volume":"10","author":"CW Tan","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0334920.ref018","article-title":"Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis","author":"K Thanapirom","year":"2025","journal-title":"Thrombosis and Haemostasis"},{"key":"pone.0334920.ref019","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2018.12.018","article-title":"Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders","volume":"174","author":"A Suzuki","year":"2019","journal-title":"Thromb Res"},{"key":"pone.0334920.ref020","article-title":"Clot waveform analysis in patients with haemophilia A.","author":"T Siegemund","year":"2014","journal-title":"Hamostaseologie"},{"issue":"14","key":"pone.0334920.ref021","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3390\/diagnostics13142447","article-title":"Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study","volume":"13","author":"WH Wong","year":"2023","journal-title":"Diagnostics (Basel)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:24:02Z","timestamp":1761326642000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334920"}},"subtitle":[],"editor":[{"given":"Kovuri","family":"Umadevi,","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334920","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}